MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Repligen Company Profile (NASDAQ:RGEN)

Consensus Ratings for Repligen (NASDAQ:RGEN) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $38.00 (5.09% downside)

Analysts' Ratings History for Repligen (NASDAQ:RGEN)
Show:
DateFirmActionRatingPrice TargetActions
4/23/2015Jefferies GroupBoost Price TargetBuy$25.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2014Jefferies GroupReiterated RatingBuy$22.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Janney Montgomery ScottInitiated CoverageBuy -> Buy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2014Jefferies GroupBoost Price TargetBuy$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Jefferies GroupInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/3/2013 forward)